The iron-sulfur helicase DDX11 promotes the generation of single-stranded DNA for CHK1 activation.


Journal

Life science alliance
ISSN: 2575-1077
Titre abrégé: Life Sci Alliance
Pays: United States
ID NLM: 101728869

Informations de publication

Date de publication:
03 2020
Historique:
received: 11 09 2019
revised: 06 02 2020
accepted: 06 02 2020
entrez: 20 2 2020
pubmed: 20 2 2020
medline: 16 3 2021
Statut: epublish

Résumé

The iron-sulfur (FeS) cluster helicase DDX11 is associated with a human disorder termed Warsaw Breakage Syndrome. Interestingly, one disease-associated mutation affects the highly conserved arginine-263 in the FeS cluster-binding motif. Here, we demonstrate that the FeS cluster in DDX11 is required for DNA binding, ATP hydrolysis, and DNA helicase activity, and that arginine-263 affects FeS cluster binding, most likely because of its positive charge. We further show that DDX11 interacts with the replication factors DNA polymerase delta and WDHD1. In vitro, DDX11 can remove DNA obstacles ahead of Pol δ in an ATPase- and FeS domain-dependent manner, and hence generate single-stranded DNA. Accordingly, depletion of DDX11 causes reduced levels of single-stranded DNA, a reduction of chromatin-bound replication protein A, and impaired CHK1 phosphorylation at serine-345. Taken together, we propose that DDX11 plays a role in dismantling secondary structures during DNA replication, thereby promoting CHK1 activation.

Identifiants

pubmed: 32071282
pii: 3/3/e201900547
doi: 10.26508/lsa.201900547
pmc: PMC7032568
pii:
doi:

Substances chimiques

Cell Cycle Proteins 0
DNA, Single-Stranded 0
DNA-Binding Proteins 0
RPA1 protein, human 0
Replication Protein A 0
WDHD1 protein, human 0
DNA 9007-49-2
CHEK1 protein, human EC 2.7.11.1
Checkpoint Kinase 1 EC 2.7.11.1
DNA Polymerase III EC 2.7.7.7
Adenosine Triphosphatases EC 3.6.1.-
DNA Helicases EC 3.6.4.-
DDX11 protein, human EC 3.6.4.13
DEAD-box RNA Helicases EC 3.6.4.13

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2020 Simon et al.

Références

Nat Chem Biol. 2011 Nov 27;8(1):125-32
pubmed: 22119860
Genetics. 2004 Jan;166(1):33-42
pubmed: 15020404
J Biol Chem. 2008 Jan 18;283(3):1732-43
pubmed: 18029358
Nat Rev Mol Cell Biol. 2017 Oct;18(10):622-636
pubmed: 28811666
Life Sci Alliance. 2019 Jul 5;2(4):
pubmed: 31278166
Mol Cell. 2020 Jan 16;77(2):395-410.e3
pubmed: 31759824
Cell. 2008 May 30;133(5):801-12
pubmed: 18510925
J Cell Sci. 2006 Dec 1;119(Pt 23):4857-65
pubmed: 17105772
Oncotarget. 2016 Oct 18;7(42):67934-67947
pubmed: 27636994
Nucleic Acids Res. 2006;34(20):5880-91
pubmed: 17062629
J Cell Sci. 2010 Mar 1;123(Pt 5):660-70
pubmed: 20124417
Chromosoma. 2013 Mar;122(1-2):121-34
pubmed: 23334284
Mol Cell. 2019 Feb 21;73(4):670-683.e12
pubmed: 30639241
PLoS Biol. 2008 Jun 24;6(6):e149
pubmed: 18578568
Mol Cell. 2006 Sep 15;23(6):801-8
pubmed: 16973432
Am J Hum Genet. 2010 Feb 12;86(2):262-6
pubmed: 20137776
Hum Mutat. 2013 Jan;34(1):103-7
pubmed: 23033317
Nucleic Acids Res. 2016 Jan 29;44(2):705-17
pubmed: 26503245
Proc Natl Acad Sci U S A. 2018 Aug 14;115(33):8412-8417
pubmed: 30061412
Cell. 2013 Nov 21;155(5):1088-103
pubmed: 24267891
J Biol Chem. 2015 May 29;290(22):14218-25
pubmed: 25897079
Mol Cell. 2003 Jun;11(6):1635-46
pubmed: 12820975
PLoS Genet. 2018 Oct 10;14(10):e1007622
pubmed: 30303954
Am J Hum Genet. 1998 Oct;63(4):1036-48
pubmed: 9758621
J Biol Chem. 2015 Feb 20;290(8):5174-89
pubmed: 25561740
J Biol Chem. 2012 Jan 6;287(2):1007-21
pubmed: 22102414
Eur J Med Genet. 2015 Apr;58(4):235-7
pubmed: 25701697
Cell Mol Life Sci. 2014 Jul;71(14):2625-39
pubmed: 24487782
Genes (Basel). 2018 Nov 21;9(11):
pubmed: 30469382
J Cell Sci. 2004 Jul 15;117(Pt 16):3547-59
pubmed: 15226378
Nucleic Acids Res. 2000 Feb 15;28(4):917-24
pubmed: 10648783
Am J Med Genet A. 2018 Nov;176(11):2404-2418
pubmed: 30216658
Cell. 2008 May 30;133(5):789-800
pubmed: 18510924
Nat Methods. 2012 Jul;9(7):671-5
pubmed: 22930834
J Cell Biol. 2019 Sep 2;218(9):2865-2875
pubmed: 31366665
Mol Cell. 2016 Aug 4;63(3):371-84
pubmed: 27397686
J Biol Chem. 2008 Jul 25;283(30):20925-36
pubmed: 18499658

Auteurs

Anna K Simon (AK)

Institute of Molecular Cancer Research, University of Zurich, Zurich, Switzerland.

Sandra Kummer (S)

Institute of Molecular Cancer Research, University of Zurich, Zurich, Switzerland.

Sebastian Wild (S)

Institute of Molecular Cancer Research, University of Zurich, Zurich, Switzerland.

Aleksandra Lezaja (A)

Department of Molecular Mechanisms of Disease, University of Zurich, Zurich, Switzerland.

Federico Teloni (F)

Department of Molecular Mechanisms of Disease, University of Zurich, Zurich, Switzerland.

Stanislaw K Jozwiakowski (SK)

Institute of Molecular Cancer Research, University of Zurich, Zurich, Switzerland.

Matthias Altmeyer (M)

Department of Molecular Mechanisms of Disease, University of Zurich, Zurich, Switzerland.

Kerstin Gari (K)

Institute of Molecular Cancer Research, University of Zurich, Zurich, Switzerland gari@imcr.uzh.ch.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH